Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Other Non Operating Income (2016 - 2025)

Angiodynamics (ANGO) has disclosed Other Non Operating Income for 16 consecutive years, with -$128000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 1166.67% year-over-year to -$128000.0, compared with a TTM value of $4.8 million through Nov 2025, up 829.33%, and an annual FY2025 reading of $4.9 million, up 705.14% over the prior year.
  • Other Non Operating Income was -$128000.0 for Q4 2025 at Angiodynamics, up from -$178000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $5.4 million in Q1 2025 and bottomed at -$352000.0 in Q3 2021.
  • Average Other Non Operating Income over 5 years is $113000.0, with a median of -$173000.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income tumbled 2420.0% in 2022, then surged 2381.51% in 2025.
  • Year by year, Other Non Operating Income stood at -$10000.0 in 2021, then crashed by 2420.0% to -$252000.0 in 2022, then surged by 87.3% to -$32000.0 in 2023, then soared by 137.5% to $12000.0 in 2024, then plummeted by 1166.67% to -$128000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for ANGO at -$128000.0 in Q4 2025, -$178000.0 in Q3 2025, and -$325000.0 in Q2 2025.